Aclarion (formerly known as Nocimed) is a healthcare technology company that designs solutions for clinical treatments. It uses magnetic resonance spectroscopy (MRS) for non-invasive quantification of chemical differences in tissues applied to assess the relative chemical biomarkers for tissue degeneration and pain. The company develops NOCISCAN, a software suite that works with existing MR systems and MRS pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs.